Requests for Applications from NIH

  • NIH-DoD-VA Pain Management Collaboratory – Pragmatic Clinical Trials Demonstration Projects (UG3/UH3)
    (RFA-AT-17-001)
    National Center for Complementary and Integrative Health
    National Institute on Alcohol Abuse and Alcoholism
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    National Institute on Drug Abuse
    National Institute of Neurological Disorders and Stroke
    National Institute of Nursing Research
    Office of Research on Women’s Health
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • NIH-DoD-VA Pain Management Collaboratory – Coordinating Center (U24)
    (RFA-AT-17-002)
    National Center for Complementary and Integrative Health
    National Institute on Drug Abuse
    Office of Research on Women’s Health
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Canine Immunotherapy Trials and Correlative Studies (U01)
    (RFA-CA-17-001)
    National Cancer Institute
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)
    (RFA-CA-17-002)
    National Cancer Institute
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Cancer Immune Monitoring and Analysis Centers (U24)
    (RFA-CA-17-005)
    National Cancer Institute
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Cancer Immunologic Data Commons (CIDC) (U24)
    (RFA-CA-17-006)
    National Cancer Institute
    Application Receipt Date(s): March 3, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)
    (RFA-CA-17-015)
    National Cancer Institute
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24)
    (RFA-CA-17-016)
    National Cancer Institute
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • NIDCR Award for Sustaining Outstanding Achievement in Research (SOAR) (R35)
    (RFA-DE-18-002)
    National Institute of Dental and Craniofacial Research
    Application Receipt Date(s): March 30, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Limited Competition: Follow-up on Subjects and Immunological Assessments in The Environmental Determinants of Diabetes In The Young Study (TEDDY) (UC4)
    (RFA-DK-16-504)
    National Institute of Diabetes and Digestive and Kidney Diseases
    National Institute of Allergy and Infectious Diseases
    Application Receipt Date(s): March 15, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Developmental Centers for Interdisciplinary Research in Benign Urology (P20)
    (RFA-DK-17-002)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 7, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Therapeutic Targeting Of The Human Islet Environment (UC4)
    (RFA-DK-17-003)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 22, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Competitive Collaborative Projects for Human Islet Biology (UC4)
    (RFA-DK-17-004)
    National Institute of Diabetes and Digestive and Kidney Diseases
    Application Receipt Date(s): March 23, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time (R01)
    (RFA-HD-18-003)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Moving Beyond Standard Assessments: Applying Novel Tools to Assess Human Placental Structure and Function in Real Time (R21)
    (RFA-HD-18-004)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Integrative Research in Gynecologic Health (R01)
    (RFA-HD-18-017)
    Eunice Kennedy Shriver National Institute of Child Health and Human Development
    Application Receipt Date(s): March 31, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on this date.
  • Innovations for Healthy Living – Improving Population Health and Eliminating Health Disparities (R43/R44)
    (RFA-MD-17-001)
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): February 22, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42)
    (RFA-MD-17-002)
    National Institute on Minority Health and Health Disparities
    Application Receipt Date(s): February 22, 2017, by 5:00 PM local time of applicant organization. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
  • Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R61/R33)
    (RFA-MH-17-600)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 15, 2017; October 15, 2017, February 15, 2018, June 15, 2018, October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Early Stage Testing of Pharmacologic or Device-based Interventions for the Treatment of Mental Disorders (R33)
    (RFA-MH-17-602)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 15, 2017; October 17, 2017, February 15, 2018, June 15, 2018, October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33)
    (RFA-MH-17-604)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33)
    (RFA-MH-17-606)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates
  • Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (R01)
    (RFA-MH-17-608)
    National Institute of Mental Health
    Application Receipt Date(s): February 15,2017; June 14, 2017; October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Clinical Trials to Test the Effectiveness of Treatment, Preventive, and Services Interventions (Collaborative R01)
    (RFA-MH-17-610)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018 , by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Pilot Effectiveness Trials for Treatment, Preventive and Services Interventions (R34)
    (RFA-MH-17-612)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 14, 2017; October 17,2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Confirmatory Efficacy Clinical Trials of Non-Pharmacological Interventions for Mental Disorders (R01)
    (RFA-MH-17-614)
    National Institute of Mental Health
    Application Receipt Date(s): February 15, 2017; June 14, 2017; October 17, 2017; February 14, 2018; June 15, 2018; October 15, 2018, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates.
  • Miner Safety and Health Training Program – Western United States (U60)
    (RFA-OH-17-001)
    National Institute for Occupational Safety and Health
    Application Receipt Date(s): February 21, 2017, by 5:00 p.m., U.S. Eastern Time. Electronically submitted applications must be submitted no later than 5:00 p.m., ET, on the listed application due date.
  • Novel Analytical Approaches for Metabolomics Data (R03)
    (RFA-RM-17-001)
    NIH Roadmap Initiatives
    Application Receipt Date(s): February 14, 2017, by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on these dates. No late applications will be accepted for this Funding Opportunity Announcement. Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.
Advertisements
This entry was posted in Uncategorized. Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s